We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Faron Pharmaceuticals Ltd on Wednesday reported positive data from an ongoing trial on patients receiving a new treat ...
Faron Pharmaceuticals Oy 27 November 2024 Faron Pharmaceuticals Ltd. ("Faron" or "the Company") Inside Information: Faron Announces Positive Phase 2 Interim Results from BEXMAB Trial to...
Faron Pharmaceuticals Oy 11 November 2024 Faron Pharmaceuticals Ltd. ("Faron" or "the Company") Pipeline Update: Targeting Soluble Clever-1 for Autoimmune Diseases Press release, 11...
Faron Pharmaceuticals Oy 05 November 2024 ("Faron" or "the Company") Composition of Faron Pharmaceutical's Shareholders' Nomination Board Company Announcement, 5 November 2024 TURKU...
Faron Pharmaceuticals Oy 22 October 2024 Faron Pharmaceuticals Ltd. ("Faron" or "the Company") Faron's Capital Markets Day 2024 - BEXMAB follow-up data and update on drug development...
Faron Pharmaceuticals Oy 07 October 2024 Faron Pharmaceuticals Ltd. ("Faron" or "the Company") Faron announces Capital Markets Day to be held on 22 October 2024 Press release, 7...
Faron Pharmaceuticals Oy 30 August 2024 Faron Pharmaceuticals Ltd. ("Faron" or "the Company") Grant of options Company announcement, August 30, 2024 TURKU, FINLAND - Faron...
Faron Pharmaceuticals Ltd on Tuesday said its loss widened in the first half of 2024, as the company successfully adv ...
Faron Pharmaceuticals Oy 27 August 2024 Faron Pharmaceuticals Ltd. ("Faron" or "the Company") Faron Reports Half-Year Financial Results, 1 January - 30 June 2024 Company Announcement...
Faron Pharmaceuticals Oy 26 August 2024 Faron Pharmaceuticals Ltd. ("Faron" or the "Company") Inside Information: FDA Grants Fast Track Designation for Bexmarilimab in r/r MDS ...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 27.5 | 19.298245614 | 142.5 | 172.5 | 142.5 | 44954 | 168.6584004 | DE |
4 | 5 | 3.0303030303 | 165 | 172.5 | 142.5 | 19785 | 161.25840947 | DE |
12 | -54 | -24.1071428571 | 224 | 228 | 142.5 | 17273 | 185.44858185 | DE |
26 | -15 | -8.10810810811 | 185 | 233 | 89 | 51990 | 139.89912783 | DE |
52 | -90 | -34.6153846154 | 260 | 360 | 89 | 38732 | 152.73959391 | DE |
156 | -137.5 | -44.7154471545 | 307.5 | 392.5 | 89 | 21341 | 197.17024937 | DE |
260 | -87.5 | -33.9805825243 | 257.5 | 560 | 89 | 34158 | 293.23916979 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions